TMCnet News

CRO Quality Benchmarking - Phase IV Service Providers (2016 Edition) - Research and Markets
[November 30, 2016]

CRO Quality Benchmarking - Phase IV Service Providers (2016 Edition) - Research and Markets


Research and Markets has announced the addition of the "CRO Quality Benchmarking - Phase IV Service Providers (8th edition)" report to their offering.

The CRO Quality Benchmarking - Phase IV Service Providers report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase IV CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.

Study Sponsors:

- Make a more informed purchase of Phase IV services by understanding which service providers best fit your company's needs

- Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes

- Pinpoint potential delivery concerns early in a sponsor-CRO relationship/ evaluation in ordr to develop proactive strategies to address potential gaps



Clinical Service Providers:

- Uncover your own - and competitor - delivery strengths and weaknesses


- Design messaging to tout your company's strengths

- Compete more effectively by understanding buyers' selection criteria and outsourcing trends

Key Topics Covered:

1. Introduction

2. Methodology

3. Respondent Demographics And Qualifications

4. Number Of Ratings Per Company

5. 5 Major Sections

6. Service Provider Selection Process

7. Service Provider Perceptions And Interactions (News - Alert)

8. Service Provider Performance And Loyalty

9. Company Service Quality Profiles

10. Study Data

11. Demographics

Companies Mentioned

  • Accelovance
  • Accenture (News - Alert)
  • BioClinica
  • Bioskin
  • CEBIS International
  • Chiltern
  • Clinipace
  • Clinlogix
  • Cognizant (News - Alert)
  • Covance
  • DaVita Clinical Research
  • ICON
  • Inamed
  • INC Research
  • inVentiv Health Clinical
  • KCR
  • Lambda
  • Mapi
  • Novum
  • PAREXEL
  • Pharm-Olam International
  • PPD
  • PRA
  • ProTrials
  • QPS
  • Quintiles
  • Radiant
  • Rho
  • SanaClis
  • SGS Life Sciences
  • SynteractHCR
  • Tata
  • Theorem
  • TKL Research
  • UBC

For more information about this report visit http://www.researchandmarkets.com/research/4qwqr7/cro_quality


[ Back To TMCnet.com's Homepage ]